• Info
  • Insider Ownership

Insider Trading & Ownership of Andrew A. Hindman

Location
Ardsley, NY
Summary
The estimated net worth of Andrew A. Hindman is at least $3,958,707 dollars as of 22 Nov 2022. Andrew A. Hindman is the SVP, CHIEF FINANCIAL OFFICER of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $3.96M.
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Andrew A. Hindman files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Andrew A. Hindman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. Svp, Chief Financial Officer $3,958,707 18 Nov 2022

Insider Transactions Reported by Andrew A. Hindman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.